Taiwan Advance Bio-Pharmaceutical Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Advance Bio-Pharmaceutical Inc with three other companies in this sector in TAIWAN : Holy Stone Healthcare Co Ltd (2019 sales of 204.16 million Taiwanese Dollars [US$6.95 million] ), Pharmaessentia Corp (305.69 million Taiwanese Dollars [US$10.41 million] of which 100% was Pharmaceutical Development), and General Biological Corporation (239.65 million Taiwanese Dollars [US$8.16 million] ).

Sales Analysis. During the year ended December of 2019, sales at Taiwan Advance Bio-Pharmaceutical Inc were 205.80 million Taiwanese Dollars (US$7.01 million). This is an increase of 22.2% versus 2018, when the company's sales were 168.35 million Taiwanese Dollars . This was the third consecutive year of growth at Taiwan Advance Bio-Pharmaceutical Inc.